Core Viewpoint - New Zhi Bio, the first stock in life science instruments listed on the Beijing Stock Exchange, emphasizes the importance of innovation and capital support for small and medium-sized enterprises, enhancing brand influence and overall capabilities in product development and market expansion [1][6]. Company Overview - New Zhi Bio is one of the earliest companies in China focused on the research, production, and sales of life science instruments, with over 20 product lines and more than 200 product models covering three main areas: biological sample processing, molecular biology and drug research, and laboratory automation [2]. - The company has transitioned from a laboratory equipment supplier to a comprehensive service provider covering the entire process from experimentation to mass production [2]. Product Development and Market Strategy - The company continues to iterate on traditional products while expanding new product lines, with a focus on customer feedback to drive product matrix enrichment [2]. - New Zhi Bio has developed specialized models for cross-industry applications, maintaining a customized business ratio of over 20% [2]. Strategic Direction and Acquisitions - The company is leveraging capital to accelerate industry integration, exemplified by the acquisition of 55% of Ningbo Afus Constant Temperature Company to enhance its industrial temperature control solutions [3]. - The acquisition aligns with New Zhi Bio's existing channels and brand advantages, providing new growth opportunities [3]. Global Expansion and Localization - New Zhi Bio is shifting its strategic focus towards high-end instruments and global layout, with an emphasis on self-sufficiency in scientific instruments [4]. - The company plans to establish a localized service network abroad, moving from reliance on foreign distributors to a "sales-application-after-sales" service model [5]. Capital Market Insights - The Beijing Stock Exchange has played a crucial role in supporting innovative SMEs, fostering a development pattern that balances quantity and quality [6]. - The listing has not only provided financial support but also enhanced talent attraction, optimized shareholder structure, and increased brand influence [6]. - New Zhi Bio aims to become a "research supermarket" and a provider of comprehensive solutions, leveraging opportunities for collaboration with leading companies in niche markets [6].
新芝生物： 攻坚中高端市场 加速全球化布局